- Login
- Register & Subscribe
- Language: EN FR DE
Regulation & Policy
European Commission proposes a relaxation of rules on drug information
Thursday 11 December 2008
The European Commission is proposing that pharmaceutical companies be allowed to provide prescription-drug information directly to consumers, provided this is not advertising.
Location
Belgium
UK government asked to raise investment in biotech
Friday 5 December 2008
A group of biotechnology company chief executives and investors has called on the UK government to contribute at least £500 million for investment in Britain’s biotech sector, which can no longer count on getting sufficient funding from private sources because of the worldwide banking crisis.
Location
United Kingdom
EMEA to propose making more regulatory data public
Wednesday 3 December 2008
The European Medicines Agency (EMEA) will soon propose a revision of its policy for the handling of commercially confidential information so as to make more regulatory documents available to the public.
Location
United Kingdom
Pfizer withdraws application to switch Viagra to OTC status
Saturday 22 November 2008
Pfizer Ltd has withdrawn its application to the European Medicines Agency to switch the classification of Viagra (sildenafil) from a prescription-only medicine to an over-the-counter medicine.
Location
United Kingdom
Six new medicines given the go-ahead by the EMEA
Saturday 22 November 2008
The European Medicines Agency has recommended that six new medicines be given marketing authorisations for the European Union.
Location
United Kingdom
Sanofi-Aventis Pharma withdraws application for new docetaxel indication
Friday 21 November 2008
Sanofi-Aventis Pharma SA has withdrawn its application to extend the indication for its cancer treatment, docetaxel, following questions from the European Medicines Agency about the design of the clinical trial used to support the proposed new use.
Location
United Kingdom
EMEA calls for suspension of Janssen-Cilag’s pain relief drug
Friday 21 November 2008
The European Medicines Agency has recommended that the marketing authorisation for Ionsys (fentanyl hydrochloride), an opioid analgesic produced by Janssen-Cilag International NV, be suspended because of a defect in the delivery system that could result in patients being overdosed. Janssen-Cilag is an affiliate of Johnson & Johnson.
Location
United States
UK announces new drug pricing agreement
Thursday 20 November 2008
The UK Department of Health has reached an agreement with the pharmaceutical industry to change the way in which drugs are priced and supplied to the National Health Service (NHS).
Location
United Kingdom
Ban proposed on the use of great apes in research
Thursday 13 November 2008
The European Commission is proposing to ban the use of great apes in scientific research in a move to tighten up the regulation of animal studies.
Location
Belgium
Sanofi-aventis discontinues all trials of Acomplia
Friday 7 November 2008
Sanofi-aventis has stopped all clinical trials of Acomplia (rimonabant), which until recently had been sold on 32 markets around the world as a treatment for obesity. The trials were being conducted in order to investigate new indications for the drug in diabetes and heart disease.
Location
France
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013